Avacta Group Plc (OTCMKTS:AVCTF – Get Free Report) traded down 3% during trading on Monday . The company traded as low as $0.82 and last traded at $0.82. 200 shares changed hands during trading, a decline of 92% from the average session volume of 2,644 shares. The stock had previously closed at $0.84.
Avacta Group Price Performance
The stock’s fifty day moving average is $0.85 and its two-hundred day moving average is $0.73.
Avacta Group Company Profile
Avacta Group Plc develops cancer therapies and diagnostics in the United Kingdom, France, North America, South Korea, and rest of Asia and Europe. The company operates through Diagnostics and Therapeutics segments. It develops products based on its proprietary Affimer and pre|CISION technology platforms.
Featured Articles
- Five stocks we like better than Avacta Group
- What is Forex and How Does it Work?
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- 10 Best Airline Stocks to Buy
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- The 3 Best Blue-Chip Stocks to Buy Now
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.
